Mary W Redman

Mary W Redman

UNVERIFIED PROFILE

Are you Mary W Redman?   Register this Author

Register author
Mary W Redman

Mary W Redman

Publications by authors named "Mary W Redman"

Are you Mary W Redman?   Register this Author

48Publications

1240Reads

6Profile Views

Quantifying treatment effects using the personalized chance of longer survival.

Stat Med 2019 Dec 9;38(28):5317-5331. Epub 2019 Sep 9.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.8363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842038PMC
December 2019

Response to H. Nabi et al.

J Natl Cancer Inst 2018 12;110(12):1424-1425

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658869PMC
December 2018

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.

J Clin Oncol 2016 11 30;34(33):3992-3999. Epub 2016 Sep 30.

Herbert H. Pang and Perry Cheng, School of Public Health, Li Ka Shing Faculty of Medicine, Hong Kong, Special Administrative Region, People's Republic of China; Herbert H. Pang, Xiaofei Wang, Ying Zhang, Thomas E. Stinchcombe, and Harvey J. Cohen, Duke University School of Medicine, Durham, NC; Melisa L. Wong, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco; David Gandara, University of California, Davis Comprehensive Cancer Center, Sacramento, CA; Apar Kishor Ganti, Veterans Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE; Daniel J. Sargent and Sumithra J. Mandrekar, Mayo Clinic, Rochester, MN; Chen Hu, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Chen Hu, Johns Hopkins University School of Medicine, Baltimore, MD; Mary W. Redman, Fred Hutchinson Cancer Research Center, Seattle, WA; Judith B. Manola, Dana-Farber Cancer Institute, Boston, MA; Richard L. Schilsky, ASCO, Alexandria, VA; Jeffrey D. Bradley, Washington University School of Medicine, St Louis, MO; Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, NY; Suresh S. Ramalingam, The Winship Cancer Institute of Emory University, Atlanta, GA; and Everett E. Vokes, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.7088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477832PMC
November 2016

The Master Protocol Concept.

Semin Oncol 2015 Oct 10;42(5):724-30. Epub 2015 Jul 10.

Department of Medicine, Division of Hematology and Oncology, University of Florida Health Cancer Center, Gainesville, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681517PMC
October 2015

Lung-MAP--framework, overview, and design principles.

Chin Clin Oncol 2015 Sep;4(3):36

Department of Thoracic and Head and Neck Medical Oncology, University of Texas, MD Anderson Cancer Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.09.02DOI Listing
September 2015

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1099-106

*Division of Biomedical Statistics and Informatics, Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota; †Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona; ‡Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; §Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, North Carolina; ‖Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, NCIC Clinical Trials Group, Queen' University, Kingston, ON, Canada; #Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia; **Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California; ††Department of Statistics for the Data Center/Operations Office, Japan Clinical Oncology Group Data Center, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan; ‡‡Department of Medical Oncology, Japanese Society of Medical Oncology, Tokyo, Japan; §§Department of Medicine, The University of Chicago Medicine and Biologic Sciences Center, Chicago, Illinois; and ‖‖Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153349
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493926PMC
July 2015

Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer".

J Thorac Oncol 2015 May;10(5):e36

University of California Davis Comprehensive Cancer Center, Sacramento, CA SWOG Statistical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000515DOI Listing
May 2015

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.

J Thorac Oncol 2015 Jan;10(1):110-5

*University of California Davis Comprehensive Cancer Center, Sacramento, California; †SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Washington; ‡Humboldt Medical Specialists, Eureka, California; and §Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320001PMC
January 2015

Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536.

J Thorac Oncol 2013 Dec;8(12):1519-28

*Levine Cancer Institute, Charlotte, North Carolina; †SWOG Statistical Center, Seattle, Washington; ‡Yale Cancer Center, New Haven, Connecticut; §Cancer Center of Kansas and Wichita CCOP, Wichita, Kansas; ‖Central Illinois CCOP and Cancer Care Specialists, Decatur, Illinois; ¶University of Colorado Cancer Center, Aurora, Colorado; #University of California Davis Cancer Center, Sacramento, California; and **MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072123PMC
December 2013

Modeling the relationship between progression-free survival and overall survival: the phase II/III trial.

Clin Cancer Res 2013 May;19(10):2646-56

Southwest Oncology Group Fred Hutchinson Cancer Research Center; Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131693PMC
May 2013

Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer.

Cancer 2012 Nov 20;118(21):5358-65. Epub 2012 Mar 20.

Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481159PMC
November 2012

Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819.

Clin Cancer Res 2012 Aug 16;18(15):4004-12. Epub 2012 May 16.

SWOG Statistical Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M3-C102, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-12-0167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409929PMC
August 2012

Do general dimensions of quality of life add clinical value to symptom data?

J Natl Cancer Inst Monogr 2007 (37):31-8

Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center/M3-C102, 1100 Fairview Ave North/Box 19024, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgm007DOI Listing
December 2007

Finasteride decreases the risk of prostatic intraepithelial neoplasia.

J Urol 2007 Jul 11;178(1):107-9; discussion 110. Epub 2007 May 11.

Department of Urology, University of Texas Health Science Center at San Antonio and Southwest Oncology Group, San Antonio, Texas 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.03.012DOI Listing
July 2007